{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:50:19Z","timestamp":1787784619840,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/rhu.0b013e3181ba3c6f","type":"journal-article","created":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T14:46:46Z","timestamp":1254581206000},"page":"363-365","source":"Crossref","is-referenced-by-count":23,"title":["Rituximab Therapy Produced Rapid and Sustained Clinical Improvement in a Patient With Systemic Onset Juvenile Idiopathic Arthritis Refractory to TNF Alpha Antagonists"],"prefix":"10.1097","volume":"15","author":[{"given":"Julio Garc\u00eda","family":"Feito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A.","family":"Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210207","first-page":"1579","article-title":"Kelley's Textbook of Rheumatology.","author":"Cassidy","year":"2005"},{"key":"R2-10-20210207","first-page":"945","article-title":"Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. Outcome status.","volume":"24","author":"Ruperto","year":"1997","journal-title":"J Rheumatol"},{"key":"R3-10-20210207","first-page":"366","article-title":"Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy.","volume":"25","author":"Flato","year":"1998","journal-title":"J Rheumatol"},{"key":"R4-10-20210207","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"R5-10-20210207","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/RHU.0b013e318188b1df","article-title":"Development of autoimmune hepatitis in a child with systemic-onset juvenile idiopathic arthritis during therapy with etanercept.","volume":"14","author":"Fathalla","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R6-10-20210207","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/RHU.0b013e318188b8d8","article-title":"Efficacy of Anakinra in a case of refractory still disease.","volume":"14","author":"Debiais","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R7-10-20210207","first-page":"330","article-title":"Successful treatment of a patient with refractory adult-onset still disease with Anakinra (letter).","volume":"9","author":"Rudinskaya","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"R8-10-20210207","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell targeted therapy with Rituximab in patients with Rheumatoid Arthritis.","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"R9-10-20210207","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood-2002-11-3547","article-title":"Rituximab for the treatment of refractory auoimmune haemolytic anaemia in children.","volume":"101","author":"Zecca","year":"2003","journal-title":"Blood"},{"key":"R10-10-20210207","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/S0022-3476(03)00382-2","article-title":"Rituximab therapy for multisystem autoimmune diseases in pediatric patients.","volume":"143","author":"Bindstadt","year":"2003","journal-title":"J Pediatr"},{"key":"R11-10-20210207","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1002\/art.21351","article-title":"B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.","volume":"52","author":"Marks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R12-10-20210207","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncprheum0424","article-title":"Drug insight: the mechanism of action of rituximab in autoimmune disease-the immune complex decoy hypothesis.","volume":"3","author":"Taylor","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"R14-10-20210207","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"R15-10-20210207","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874312900802010081","article-title":"Frequency of regulatory T cells is not affected by transient B cell depletion using Anti-CD20 antibodies in rheumatoid arthritis.","volume":"2","author":"Feuchtemberger","year":"2008","journal-title":"Open Rheumatol J"},{"key":"R16-10-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1136\/ard.2008.092106","article-title":"Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.","volume":"68","author":"Narvaez","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R17-10-20210207","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2141.2009.07715.x","article-title":"Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.","volume":"146","author":"Cooper","year":"2009","journal-title":"Br J Haematol"},{"key":"R18-10-20210207","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/rheumatology\/kel301","article-title":"Successful treatment of refractory polyarticular juvenile idiopathic arthritis with rituximab.","volume":"45","author":"Kuek","year":"2006","journal-title":"Rheumatology"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RHU.0b013e3181ba3c6f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:56Z","timestamp":1786039256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00124743-200910000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181ba3c6f","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}